Therapeutic Vaccines MarketSize and Trends

Therapeutic Vaccines Market Taxonomy:

By Vaccines Type

Auto Immune Diseases Vaccines
Neurological Disease Vaccines
Cancer Vaccines
Infectious Diseases Vaccines

By Indication

Cancer

Breast Cancer
Prostate Cancer
Lung cancer
Melanoma
others

Infectious Disease

HIV
Hepatitis B
Hepatitis C
Others

Other Chronic Diseases

Alzheimer’s
Allergy
Others

Rising demand for biologics and drugs for specific treatment is expected to favor growth of the therapeutic vaccines market in the near future

The global therapeutic vaccines market is significantly affected by increasing prevalence of cancer, HIV infection, cardiovascular diseases, and various chronic diseases. This exponential growth in prevalence of such diseases is expected to increase the demand for biologic drugs for specific or targeted response, which is further projected to support increase in growth of therapeutic vaccines industry in the near future. According to AVERT, a global organization involved in providing information and education on HIV and AIDS to the general population, in 2016, around 37 million people worldwide were infected by HIV and 40% were unaware about it. According to a report by America’s Biopharmaceutical Research Companies, in 2013, around 300 vaccines were in development, with research focused on prevention and treatment. These vaccines include treatment of various health issues and diseases such as allergy, cancer, infectious disease, and neurological disorder. Furthermore, according to data from the U.S. Centers for Disease Control and Prevention (CDC), therapeutic vaccines have led to the eradication of around 10 infectious diseases by up to 90% in the U.S.